ARTICLE | Clinical News
Lynparza olaparib: Phase III data
October 31, 2016 7:00 AM UTC
Top-line data from the double-blind, international Phase III SOLO-2 trial in 295 patients with platinum-sensitive, relapsed or recurrent BRCA-mutant ovarian cancer showed that maintenance treatment wi...